This finding is not surprising because an extensive body of literature has demonstrated that MF and SS are the most common entities, representing more than half of all PCLs, followed by CD30-positive lymphoproliferative disorders [5]. The gene discussed is TNFRSF8; the disease is lymphoproliferative syndrome.